Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 5 of 5 for “"proliferative index"”.

  1. EGFR in Early Non-small Cell Lung Cancer: Tyrosine Kinase Inhibition in a Neoadjuvant Trial

    … by reduction in tumour cellularity and proliferative index as well as presence of non-mucinous BAC histology. Clinical PR tumours also presented large areas of stromal fibrosis with presence of focal residual tumour. In a characterization of intracellular signalling response, EGFR …

    toronto-retro Repository record for EGFR in Early Non-small Cell Lung Cancer: Tyrosine Kinase Inhibition in a Neoadjuvant Trial (opens in a new tab)

  2. Role of interleukin-6 signaling via the Jak/Stat pathway in human myeloma and effects on mediators of cell survival and proliferation

    … marrow of monoclonal plasma cells with a low proliferative index and an extended life span. Interleukin-6 (IL-6) is the major survival factor for myeloma tumor cells and induces signaling through the Signal Transducer and Activator of Transcription (STAT) proteins. We report that one STAT …

    arizona-thes Repository record for Role of interleukin-6 signaling via the Jak/Stat pathway in human myeloma and effects on mediators of cell survival and proliferation (opens in a new tab)

  3. Neuroendocrine neoplasms of the digestive tract: retrospective classification according to the 2019 WHO grading system, and evaluation of the immunohistochemical marker INSM1

    … 2 or 3) by evaluating the mitotic rate and Ki-67 proliferative index. The most recent grading system was published in 2019 by the World Health Organisation (WHO). Insulinoma-associated protein 1 (INSM1) is a transcription factor that is expressed in neuroendocrine cells, and recent studies have …

    cape-town Repository record for Neuroendocrine neoplasms of the digestive tract: retrospective classification according to the 2019 WHO grading system, and evaluation of the immunohistochemical marker INSM1 (opens in a new tab)

  4. Molecular Biomarkers in Triple-Negative Breast Cancer // Молекулярни биомаркери при тройно негативни карциноми на гърдата

    Тройно негативният карцином на гърдата (ТНКГ), характеризиращ се с липса на експресия на рецептори за естроген, прогестерон и HER2, е с най-агресивно поведение, най-висок риск от метастази и рецидив. Целта на проучването е да се изследва прогностичната ролята на тумор инфилтриращите лимфоцити …

    varna Repository record for Molecular Biomarkers in Triple-Negative Breast Cancer // Молекулярни биомаркери при тройно негативни карциноми на гърдата (opens in a new tab)